ACC Live Courses
For a listing of all ACC Live Courses please visit: https://www.acc.org/education-and-meetings/meetings


RSS Latest in Cardiology from ACC.org

  • ACC CardiaCast: ATTR-CM Treatment: Recent Updates
    In this episode, Drs. Ahmad Masri and Kevin Alexander review emerging clinical data in transthyretin amyloid cardiomyopathy (ATTR-CM) presented at the Heart Failure Society of America Annual Scientific Meeting and the American Heart Association Scientific Sessions 2025, including key findings from the ATTRibute-CM and HELIOS-B trials.
  • Is ApoB an Appropriate Cost-Effective Marker For Lipid-Lowering Therapy?
    Apolipoprotein B (apoB) may be used as a cost-effective marker to improve population health and guide lipid-lowering therapy (LLT) in primary prevention, according to a computer simulation study published April 8 in JAMA.
  • Higher CV Risk With Hematological Malignancies Varies By Subtype
    Patients and survivors of hematological malignancies face substantially elevated short- and long-term risk of cardiovascular disease compared with the general population – with risk varying significantly by malignancy subtype, according to a population-based cohort study published April 8 in JACC.
  • Is PCI Superior to Medical Therapy For CTO in Patients With CCS?
    In patients with chronic coronary syndrome (CCS) with a single chronic total coronary occlusion (CTO) and no significant concomitant lesion, there was a greater improvement in quality of life (QoL) and symptom relief at 12 months, with no signal of excess harm, compared with optimal medical therapy (OMT)...
  • ACC Asia 2026: Sex-Specific Differences in CVD Risk Factors in South Korea
    In adults with cardiovascular disease in South Korea, the rates of awareness and treatment of key cardiovascular risk factors were higher in women than in men, but they had lower rates of risk factor control, particularly for hypertension and hypercholesterolemia...